Brain Asset Management Co.,Ltd.
Seoulbrainib.com
Overview
Brain Asset Management is a South Korea-based asset management firm with business areas in hedge funds, private equity, managed accounts, and investment advisory. The firm invests in public securities, pre-IPO shares, and mezzanine securities, utilizing strategies such as equity long/short, event-driven, and relative value.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| OLIX | Aug 2025 | Private Placement | Co-investor |
| ImmunoBiome Inc. | Jan 2022 | Series B | Co-investor |
| PDC*line Pharma | Dec 2021 | Series B Extension | Co-investor |
| Wyatt Co., Ltd. | Aug 2021 | Growth Equity | Co-investor |
| CoImmune, Inc. | Nov 2020 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
